ChemicalBook > CAS DataBase List > Everolimus Ring-Opening Impurity

Everolimus Ring-Opening Impurity

Everolimus Ring-Opening Impurity Structure
Everolimus Ring-Opening Impurity
  • CAS No.1708118-13-1
  • Chemical Name:Everolimus Ring-Opening Impurity
  • CBNumber:CB02737607
  • Molecular Formula:C53H83NO14
  • Formula Weight:958.23
  • MOL File:1708118-13-1.mol
Everolimus Ring-Opening Impurity Property
  • Melting point 45-50°C
  • Boiling point 954.8±75.0 °C(predicted)
  • Density 1.15±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)
  • storage temp. Amber Vial, -86°C Freezer, Under inert atmosphere
  • solubility Chloroform (Slightly), Methanol (Slightly)
  • form Solid
  • pka 10.56±0.60(predicted)
  • color White to Off-White
  • Stability Light and temperature Sensitive
Hazard and Precautionary Statements (GHS)
  • Symbol(GHS)
  • Signal word
  • Hazard statements
  • Precautionary statements

Everolimus Ring-Opening Impurity Chemical Properties,Usage,Production

  • Uses Everolimus Retroaldol Degradation Product is an impurity of Everolimus (E945400). Everolimus is a derivative of Rapamycin. Everolimus inhibits cytokine-mediated lymphocyte proliferation. Everolimus Impurity D
Everolimus Ring-Opening Impurity Preparation Products And Raw materials
Raw materials
Preparation Products
Global(38)Suppliers
  • Supplier:
    Standardpharm Co. Ltd.
  • Tel:86-714-3992388
  • Email:overseasales1@yongstandards.com
  • Country:United States
  • ProdList:14332
  • Advantage:58
  • Supplier:
    Moxin Chemicals
  • Tel: +8617320513646
  • Email:Anna@molcoo.com
  • Country:China
  • ProdList:9434
  • Advantage:58
  • Supplier: BOC Sciences
  • Tel: 16314854226
  • Email:info@bocsci.com
  • Country:United States
  • ProdList:9923
  • Advantage:65
Everolimus Ring-Opening Impurity Spectrum
1708118-13-1, Everolimus Ring-Opening ImpurityRelated Search:
  • 杂质对照品
  • 对照品-杂质对照品
  • 依维莫司杂质42
  • 依维莫司杂质C开环依维莫司
  • 依维莫司杂质3(012-99)
  • 依维莫司逆羟醛降解产物
  • 依维莫司开环杂质(异构体混合物)
  • 依维莫司开环醛杂质(依维莫司杂质3)
  • 依维莫司杂质2(012-99)
  • 依维莫司杂质29
  • 依维莫司杂质012-99
  • 1708118-13-1
  • Everolimus Impurity 3 (012-99)
  • Everolimus impurity 42
  • 2-Piperidinecarboxylic acid, 1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrien-1-yl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]-2-oxoacetyl]-, (1S,4R,5E)-1-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl]-4,6-dimethyl-3,7-dioxo-5-hepten-1-yl ester, (2S)-
  • EVEROLIMUS RETROALDOL DEGRADATION (ISOMER 1 + ISOMER 2)
  • Everolimus Ring-Opening Impurity (Mixture of Isomers)
  • 2-Piperidinecarboxylic acid, 1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrien-1-yl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]-2-oxoacetyl]-, (1S,4R,5E)-1-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl]-4,6-dimethyl-3,7-d...
  • Everolimus Impurity 2(012-99)
  • (S)-(2R,3S,6R,E)-1-((1S,3R,4R)-4-(2-Hydroxyethoxy)-3-methoxycyclohexyl)-2,6,8-trimethyl-5,9-dioxonon-7-en-3-yl 1-(2-((2R,3R,6S)-6-((2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxotrideca-3,5,7-trien-1-yl)-2-hydroxy-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylate
  • (2R,3S,6R,E)-1-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-2,6,8-trimethyl-5,9-dioxonon-7-en-3-yl (S)-1-(2-((2R,3R,6S)-6-((2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxotrideca-3,5,7-trien-1-yl)-2-hydroxy-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylate
  • Everolimus Impurity 33
  • Everolimus Open-Ring Aldehyde Impurity
  • Everolimus Open-Ring Impurity
  • Everolimus Impurity 012-99
  • (S)-(2R,3S,6R,E)-1-((1S,3R,4R)-4-(2-hydroxyethoxy)
  • EverolimusRetroaldolDegradationProduct